MedPath

Negative Pressure Wound Therapy -PREVENA in Prevention of Infections After Total Knee Arthroplasty (TKA)

Phase 2
Conditions
Total Knee Replacement
Interventions
Device: Negative Pressure Wound Therapy (NPWT)
Drug: standard prophylactic therapy
Registration Number
NCT02118558
Lead Sponsor
Hadassah Medical Organization
Brief Summary

This trial is a prospective, single center, unblinded, randomized, controlled study to assess the safety and efficacy of negative pressure wound therapy in preventing infections after TKA surgery . The study will enroll 316 patients that will undergo TKA. patients will be randomized to the treatment group and undergo the study intervention - (NPWT) The intervention will take place at the end of the surgery. The Patients that are randomized to the control group will receive standard treatment. Both groups will be assessed at two weeks and six weeks. period.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • Ages: 18 to 80
  • Males- not involved in active military duty.
  • Females-non child bearing potential, or females of child-bearing potential who have a negative pregnancy test (hCG urine) within 72 hours of informed consent.
Exclusion Criteria
  • Active systemic or local infection.
  • History of malignancy, radiotherapy, or chemotherapy for malignancy (except BCC of the skin)
  • Active autoimmune disease.
  • Any past or present immunosuppressive treatment.
  • Current treatment with chemotherapeutic agents
  • History of metabolic bone disease (primary or secondary).
  • Chronic renal insufficiency (defined by 50% increase of normal levels).

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Negative Pressure Wound Therapy (NPWT)Negative Pressure Wound Therapy (NPWT)-
standard prophylactic therapystandard prophylactic therapy-
Primary Outcome Measures
NameTimeMethod
The primary endpoint of the study is to evaluate the proportion of infections at the treatment and control groups after six weekssix weeks

The primary endpoint of the study is to evaluate the proportion of infections at the treatment and control groups after six weeks

Secondary Outcome Measures
NameTimeMethod
1. To assess the proportion on infections at two weeks and 6 weeks of follow-up.two weeks and six weeks

To assess the proportion on infections at two weeks and 6 weeks of follow-up.

The number of patients recommended to undergo further procedural intervention because of the infection.12 MONTHS

The number of patients recommended to undergo further procedural intervention because of the infection.

© Copyright 2025. All Rights Reserved by MedPath